TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Faransawi - Medical AB
Closing information (x1000 NOK)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
179
|
110 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
101
|
37 | |
EBITDA |
101
|
37 | |
Total assets |
174
|
148 | |
Current assets |
174
|
148 | |
Current liabilities |
40
|
31 | |
Equity capital |
135
|
116 | |
- share capital |
51
|
47 | |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
77.6%
|
78.4% | |
Turnover per employee |
179
|
110 | |
Profit as a percentage of turnover |
56.4%
|
33.6% | |
Return on assets (ROA) |
58.0%
|
25.0% | |
Current ratio |
435.0%
|
477.4% | |
Return on equity (ROE) |
74.8%
|
31.9% | |
Change turnover |
62
|
11 | |
Change turnover % |
-5%
|
53%
|
12% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.